Apr 26, 2026
04:12 AM
BSCPLC
Q3 Financials
(Continuation news of BSCPLC): As such there is a positive impact of EPS enhancement. There was no significant Extraordinary Transactions during this period. Net operating cash flows per share: Net operating cash flows per share has been increased mainly due to ordinary course of business activities. Net Asset Value per Share: Net Asset value per share has been increased mainly due to ordinary course of business activities. (end)
Apr 26, 2026
04:12 AM
BSCPLC
Q3 Financials
(Continuation news of BSCPLC): Explanatory notes for the significant variations: Significant Increase in EPS: The increase in EPS is the result of increase in revenue and other income for the ordinary course of the business activities which has been disclosed in the notes 33 to 37 in the Revenue Part of the Statement of Profit or Loss and Other Comprehensive Income for the period under consideration. (cont.2)
Apr 26, 2026
04:12 AM
BSCPLC
Q3 Financials
(Q3 Un-audited): Diluted EPS was Tk. 3.49 for Jan 2026-Mar 2026 as against Tk. 2.33 for Jan 2025-Mar 2025; Diluted EPS was Tk. 10.57 for Jul 2025-Mar 2026 as against Tk. 6.83 for Jul 2024-Mar 2025. NOCFPS was Tk. 9.76 for Jul 2025-Mar 2026 as against Tk. 7.83 for Jul 2024-Mar 2025. NAV per share was Tk. 98.71 as on Mar 2026 and NAV per share Tk. 90.99 as on Jun 2025. (cont.1)
Apr 26, 2026
04:12 AM
HAKKANIPUL
Q3 Financials
(Continuation news of HAKKANIPUL): Reasons for Deviation in EPS and NOCFPS: The increase in EPS compared to the previous period was primarily driven by improved cost efficiency, as evidenced by a reduction in cost of sales. The increase in NOCFPS over the previous period was primarily driven by a reduction in operating expenses, reflecting improved cost efficiency. (end)
Apr 26, 2026
04:12 AM
HAKKANIPUL
Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.04 for January-March 2026 as against Tk. 0.03 for January-March 2025; EPS was Tk. 0.31 for July 2025-March 2026 as against Tk. 0.28 for July 2024-March 2025. NOCFPS was Tk. 4.56 for July 2025-March 2026 as against Tk. 3.78 for July 2024-March 2025. NAV per share with revaluation was Tk. 24.32 as on March 31, 2026 and Tk. 24.24 as on June 30, 2025. NAV per share without revaluation was Tk. 12.29 as on March 31, 2026 and Tk. 11.92 as on June 30, 2025. (cont.)
Apr 26, 2026
04:12 AM
PEOPLESINS
Q1 Financials
(Q1 Un-audited): EPS was Tk. 1.29 for January-March 2026 as against Tk. 0.63 for January-March 2025. NOCFPS was Tk. 0.93 for January-March 2026 as against Tk. 0.78 for January-March 2025. NAV per share was Tk. 39.24 as on March 31, 2026 and Tk. 35.44 as on March 31, 2025. EPS and NOCFPS have been increased due to fact that Agency Commission, Management Expenses and Claims Paid less Re-Insurance amount during the current quarter are less than that of corresponding period of previous year same quarter.
Apr 26, 2026
04:12 AM
VAMLRBBF
Q1 Financials
(Q1 Un-audited): EPU was Tk. 0.27 for January-March 2026 as against Tk. (0.02) for January-March 2025. NOCFPU was Tk. 0.05 for January-March 2026 as against Tk. 0.08 for January-March 2025. NAV per unit was Tk. 11.49 (Cost price) and Tk. 8.65 (Market price) as on March 31, 2026 and Tk. 11.47 (Cost price) and Tk. 8.38 (Market price) as on December 31, 2025.
Apr 26, 2026
04:12 AM
CITYGENINS
Q1 Financials
(Cont. News of CITYGENINS): NAV has been increased for the period from 1st January 2026 to 31st March, 2026 because the company's investments in FDR and Bangladesh Govt. Treasury Bonds have been increased. (end)
Apr 26, 2026
04:12 AM
CITYGENINS
Q1 Financials
(Cont. News of CITYGENINS): to the same period of the previous year 2025 because of investment and others income have been increased. NOCFPS has been increased for the period from 1st January 2026 to 31st March, 2026 in comparison to the same period of the previous year 2025 because the company's agency commission, management expenses have been decreased sharply. (cont.2)
Apr 26, 2026
04:12 AM
CITYGENINS
Q1 Financials
(Q1 Un-audited): EPS was Tk. 1.10 for January-March 2026 as against Tk. 0.90 for January-March 2025; NOCFPS was Tk. 1.30 for January-March 2026 as against Tk. 1.16 for January-March 2025. NAV per share was Tk. 24.52 as on March 31, 2026 and Tk. 23.24 as on December 31, 2025. Reasons for deviation: EPS has been increased for the period from 1st January 2026 to 31st March, 2026 in comparison (cont.1)
Apr 26, 2026
04:12 AM
KAY&QUE
Q3 Financials
(Q3 Un-audited): EPS was Tk. 4.06 for January-March 2026 as against Tk. 2.03 for January-March 2025; EPS was Tk. 9.89 for July 2025-March 2026 as against Tk. 3.69 for July 2024-March 2025. NOCFPS was Tk. 7.00 for July 2025-March 2026 as against Tk. 4.31 for July 2024-March 2025. NAV per share was Tk. 111.61 as on March 31, 2026 and Tk. 101.72 as on June 30, 2025.
Apr 26, 2026
04:12 AM
SAMORITA
Q3 Financials
(Cont. News of SAMORITA): Reasons for deviation: NOCFPS increased from Tk. 1.53 to Tk.1.92 mainly due to cash receipts from customers have been increased by Tk. 0.76 crore over cash paid to suppliers & employees. (end)
Apr 26, 2026
04:12 AM
SAMORITA
Q3 Financials
(Q3 Un-audited): EPS was Tk. (0.06) for January-March 2026 as against Tk. 0.30 for January-March 2025; EPS was Tk. 0.77 for July 2025-March 2026 as against Tk. 0.90 for July 2024-March 2025. NOCFPS was Tk. 1.92 for July 2025-March 2026 as against Tk. 1.53 for July 2024-March 2025. NAV per share was Tk. 48.67 as on March 31, 2026 and Tk. 48.39 as on June 30, 2025. (cont.)
Apr 26, 2026
04:12 AM
ANLIMAYARN
Q3 Financials
(Q3 Un-audited): EPS was Tk. (1.23) for January-March 2026 as against Tk. (1.03) for January-March 2025; EPS was Tk. (2.81) for July 2025-March 2026 as against Tk. (2.36) for July 2024-March 2025. NOCFPS was Tk. (1.67) for July 2025-March 2026 as against Tk. (0.98) for July 2024-March 2025. NAV per share was Tk. 2.83 as on March 31, 2026 and Tk. 5.63 as on June 30, 2025.
Apr 26, 2026
04:12 AM
EPGL
Q3 Financials
(Continuation news of EPGL): This structure is expected to reduce debt-servicing pressure, stabilize cash flows, and allow management to focus on operational recovery. As a result, the Company is well-positioned to rebuild retained earnings and progressively enhance NAVPS over the medium to long term. (end)
Apr 26, 2026
04:12 AM
EPGL
Q3 Financials
(Continuation news of EPGL): due to hike in interest rates resulting in negative EPS. The temporary decline in retained earnings and NAVPS largely reflects industry-wide revenue compression, elevated financing costs, and legacy debt obligations. However, the Company has now secured a 10-year restructured financing facility from Bangladesh Bank, including a 2-year moratorium period, which significantly strengthens near-term liquidity by deferring principal repayments. (cont.3)
Apr 26, 2026
04:12 AM
EPGL
Q3 Financials
(Continuation news of EPGL): Reasons for deviation: The net loss occurred in last nine months mainly due to constraints in opening new LCs arising from the recently completed loan rescheduling process with Bangladesh Bank, coupled with high fixed factory overheads and relatively fixed administrative and distribution expenses that could not be reduced in line with the decline in revenue. Side by side incurring a huge finance charge than last year (cont.2)
Apr 26, 2026
04:12 AM
EPGL
Q3 Financials
(Q3 Un-audited): EPS was Tk. (0.89) for January-March 2026 as against Tk. (0.11) for January-March 2025; EPS was Tk. (7.62) for July 2025-March 2026 as against Tk. (1.09) for July 2024-March 2025. NOCFPS was Tk. 0.12 for July 2025-March 2026 as against Tk. 0.09 for July 2024-March 2025. NAV per share with revaluation was Tk. 25.21 as on March 31, 2026 and Tk. 32.86 as on June 30, 2025. NAV per share without revaluation was Tk. 13.51 as on March 31, 2026 and Tk. 21.16 as on June 30, 2025. (cont.1)
Apr 26, 2026
04:12 AM
NPOLYMER
Q3 Financials
(Cont. News of NPOLYMER): Reasons for deviation: During this period the Company's revenue from sales declined. Besides, high cost of raw materials has affected the profitability of the company. As a result, during this period Earnings Per Share (EPS) of the company decreased significantly compared to the previous period. (end)
Apr 26, 2026
04:12 AM
NPOLYMER
Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.17 for January-March 2026 as against Tk. 0.33 for January-March 2025; EPS was Tk. 0.25 for July 2025-March 2026 as against Tk. 0.71 for July 2024-March 2025. NOCFPS was Tk. 7.61 for July 2025-March 2026 as against Tk. 6.40 for July 2024-March 2025. NAV per share was Tk. 29.48 as on March 31, 2026 and Tk. 29.65 as on June 30, 2025. (cont.)
Apr 26, 2026
04:12 AM
HEIDELBCEM
Q1 Financials
(Continuation news of HEIDELBCEM): EPS declined in the same period of the previous year, mainly driven by increased raw material costs that could not be fully passed on to customers through sales prices due to intense market competition. NOCFPS improved compared to the same period last year, largely attributable to reduced payments to suppliers, particularly for raw materials, as well as lower operating expense outflows. (end)
Apr 26, 2026
04:12 AM
HEIDELBCEM
Q1 Financials
(Q1 Un-audited): EPS was Tk. (0.88) for January-March 2026 as against Tk. 3.48 for January-March 2025. NOCFPS was Tk. 7.49 for January-March 2026 as against Tk. (2.97) for January-March 2025. NAV per share was Tk. 73.04 as on March 31, 2026 and Tk. 73.92 as on December 31, 2025. For the period from January to March 2026, NAV per share decreased due to the net loss incurred during the period. (cont.)